Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Assets Average (2020 - 2026)

BioScience Health Innovations has reported Assets Average over the past 7 years, most recently at $2.0 million for Q1 2026.

  • Quarterly Assets Average rose 77.96% to $2.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Mar 2026, up 77.96% year-over-year, with the annual reading at $1.3 million for FY2025, 166.86% up from the prior year.
  • Assets Average was $2.0 million for Q1 2026 at BioScience Health Innovations, up from $1.9 million in the prior quarter.
  • Over five years, Assets Average peaked at $2.1 million in Q3 2025 and troughed at $20354.5 in Q3 2022.
  • The 5-year median for Assets Average is $124093.0 (2024), against an average of $618629.3.
  • The largest YoY upside for Assets Average was 3366.2% in 2022 against a maximum downside of 56.47% in 2022.
  • A 5-year view of Assets Average shows it stood at $22298.0 in 2022, then skyrocketed by 322.43% to $94194.5 in 2023, then soared by 584.55% to $644809.0 in 2024, then surged by 192.67% to $1.9 million in 2025, then rose by 6.97% to $2.0 million in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Assets Average are $2.0 million (Q1 2026), $1.9 million (Q4 2025), and $2.1 million (Q3 2025).